Earlier this month, the turf was cut and construction initiated on Cell Therapy Catapult’s £55 million cell and gene therapy manufacturing centre in Stevenage. The Cell Therapy Catapult manufacturing centre is due to be completed and opened in 2017. When completed, the venue will be spread over a 7,200m2 area.
The centre will directly create up to 150 specialist jobs, and many more additional roles in the cluster that grows around it. The UK government and Cell Therapy Catapult also anticipate the centre will attract considerable inward investment to the UK. Most importantly, by providing a direct solution to central challenges for the development of cellular therapies, it will speed up the developments of critically needed treatments for patients in the UK and internationally.
Do you have a video you would like the sector to see? Contact us.